Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and progesterone for endometrial hyperplasia
IRCT20230128057254N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin and progesterone in endometrial hyperplasia (EH), sponsored by Qazvin University of Medical Sciences. Started May 2023; status: completed.
02
Drugs
metforminprogesterone
03
Conditions
endometrial hyperplasia (EH)
Beyond the preview
Go deeper on IRCT20230128057254N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230128057254N1.